4-46051497-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_173536.4(GABRG1):c.1058C>T(p.Thr353Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000315 in 1,459,438 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_173536.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GABRG1 | NM_173536.4 | c.1058C>T | p.Thr353Ile | missense_variant | 8/9 | ENST00000295452.5 | NP_775807.2 | |
GABRG1 | XM_017007990.2 | c.671C>T | p.Thr224Ile | missense_variant | 6/7 | XP_016863479.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GABRG1 | ENST00000295452.5 | c.1058C>T | p.Thr353Ile | missense_variant | 8/9 | 1 | NM_173536.4 | ENSP00000295452.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000800 AC: 2AN: 249886Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135096
GnomAD4 exome AF: 0.0000315 AC: 46AN: 1459438Hom.: 0 Cov.: 31 AF XY: 0.0000289 AC XY: 21AN XY: 726038
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 26, 2024 | The c.1058C>T (p.T353I) alteration is located in exon 8 (coding exon 8) of the GABRG1 gene. This alteration results from a C to T substitution at nucleotide position 1058, causing the threonine (T) at amino acid position 353 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at